118 related articles for article (PubMed ID: 19557588)
1. Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice.
Iizuka K; Hamaue N; Machida T; Hirafuji M; Tsuji M
Endocr Res; 2009; 34(1-2):18-30. PubMed ID: 19557588
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone-induced body weight gain is prevented by combined administration with the lipoprotein lipase activator NO-1886.
Kusunoki M; Tsutsumi K; Sato D; Nakamura A; Habu S; Mori Y; Morishita M; Yonemoto T; Miyata T; Nakaya Y; Nakamura T
Eur J Pharmacol; 2011 Oct; 668(3):486-91. PubMed ID: 21835171
[TBL] [Abstract][Full Text] [Related]
3. Sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, attenuates neurogenic pain induced by nucleus pulposus in rats.
Hashizume H; Kawakami M; Yoshida M; Okada M; Enyo Y; Inomata Y
Spine (Phila Pa 1976); 2007 Feb; 32(3):315-20. PubMed ID: 17268262
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
5. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice.
Itoh T; Kobayashi M; Horio F; Furuichi Y
Nutrition; 2009 Feb; 25(2):134-41. PubMed ID: 18929464
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
[TBL] [Abstract][Full Text] [Related]
7. Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine(2A) antagonist, augments autologous bone marrow mononuclear cell implantation-induced improvement in endothelium-dependent vasodilation in patients with critical limb ischemia.
Higashi Y; Miyazaki M; Goto C; Sanada H; Sueda T; Chayama K
J Cardiovasc Pharmacol; 2010 Jan; 55(1):56-61. PubMed ID: 19834330
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of sarpogrelate, a 5-HT2A receptor antagonist on cytokine production in endotoxin shock model of rats.
Nishiyama T
Eur J Pharmacol; 2009 Jul; 614(1-3):122-7. PubMed ID: 19318092
[TBL] [Abstract][Full Text] [Related]
9. Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
Miyazaki M; Higashi Y; Goto C; Chayama K; Yoshizumi M; Sanada H; Orihashi K; Sueda T
J Cardiovasc Pharmacol; 2007 Apr; 49(4):221-7. PubMed ID: 17438407
[TBL] [Abstract][Full Text] [Related]
10. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients.
Ogawa S; Takeuchi K; Sugimura K; Sato C; Fukuda M; Lee R; Ito S; Sato T
Clin Exp Pharmacol Physiol; 1999; 26(5-6):461-4. PubMed ID: 10386239
[TBL] [Abstract][Full Text] [Related]
12. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice.
Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
Eur J Pharmacol; 2009 Jan; 602(2-3):448-54. PubMed ID: 19038243
[TBL] [Abstract][Full Text] [Related]
13. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
[TBL] [Abstract][Full Text] [Related]
14. Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.
Nonogaki K; Nozue K; Oka Y
Biochem Biophys Res Commun; 2006 Dec; 351(4):1078-82. PubMed ID: 17097612
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components.
Yang CY; Wang J; Zhao Y; Shen L; Jiang X; Xie ZG; Liang N; Zhang L; Chen ZH
J Ethnopharmacol; 2010 Jul; 130(2):231-6. PubMed ID: 20435129
[TBL] [Abstract][Full Text] [Related]
16. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
[TBL] [Abstract][Full Text] [Related]
17. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy.
Kiyici S; Ersoy C; Oz Gul O; Sarandol E; Demirci M; Tuncel E; Sigirli D; Erturk E; Imamoglu S
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):386-90. PubMed ID: 19629933
[TBL] [Abstract][Full Text] [Related]
18. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus.
Harashima K; Hayashi J; Miwa T; Tsunoda T
Metabolism; 2009 Jun; 58(6):739-45. PubMed ID: 19446110
[TBL] [Abstract][Full Text] [Related]
19. Reductive effect of hot-water extracts from woody ear (Auricularia auricula-judae Quel.) on food intake and blood glucose concentration in genetically diabetic KK-Ay mice.
Takeujchi H; He P; Mooi LY
J Nutr Sci Vitaminol (Tokyo); 2004 Aug; 50(4):300-4. PubMed ID: 15527075
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of sarpogrelate action in improving cardiac function in diabetes.
Goyal RK; Elimban V; Xu YJ; Kumamoto H; Takeda N; Dhalla NS
J Cardiovasc Pharmacol Ther; 2011; 16(3-4):380-7. PubMed ID: 21183729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]